{
    "general": "This act helps control the cost of medicine and other medical supplies used by the National Health Service (NHS). It requires companies that make and sell these items to give the government information about their prices so that they can be sure they are not charging too much. This will help keep costs down and ensure that patients receive good value for money. The act also makes sure that companies provide accurate information about their products so that doctors and other healthcare professionals have the right information when making decisions about patient care.",
    "series": [
        [
            {
                "length": 177,
                "short": "\"UK Healthcare Cost Control Measures\"",
                "text": "\n* Simplified point 1: The text pertains to controlling the cost of health service medicines in the UK.\n* Simplified point 2: It introduces new provisions for remuneration for special medicinal products, including requirements for determining authorities to ensure that remuneration is reasonable and procedures for estimating an amount of remuneration that is reasonable.\n* Simplified point 3: The text also includes provisions for voluntary schemes and statutory schemes for controlling the cost of health service medicines, as well as enforcement measures for non-compliance.\n* Simplified point 4: The changes aim to ensure that medicinal products are available for the health service on reasonable terms while considering the costs of research and development."
            },
            {
                "length": 239,
                "short": "\"Government Control of Medical Supply Prices: Regulatory Measures and Enforcement\"",
                "text": "\n* Simplified point 1: The Health Service Medical Supplies (Costs) Act 2017 allows the government to control the maximum price of medical supplies other than health service medicines.\n* Simplified point 2: Before making an order to control the maximum price, the Secretary of State must consult with bodies that represent manufacturers, distributors, and suppliers of medical supplies.\n* Simplified point 3: The act also gives the government the power to enforce the orders made under section 260, and any breach of these orders can lead to penalties.\n* Simplified point 4: The act extends to Scotland and Northern Ireland, and it includes provisions for the recovery of costs incurred in enforcing the orders.\n* Simplified point 5: The act repeals and replaces previous provisions related to the control of prices of medical supplies, and it introduces new provisions for the recovery of costs incurred in enforcing the orders."
            },
            {
                "length": 150,
                "short": "\"Healthcare Product Information Disclosure Requirements\"",
                "text": "\n* Simplified point 1: The provision of information to the Secretary of State regarding the cost of healthcare products.\n* Simplified point 2: The requirement for UK producers to record and keep information about their products' prices, profits, and other relevant details.\n* Simplified point 3: The ability of the Secretary of State to request information from UK producers regarding their products' costs and profits.\n* Simplified point 4: The prohibition against using information obtained through these provisions for any purpose other than verifying whether health service products are UK health service products and determining the adequacy of supplies."
            },
            {
                "length": 216,
                "short": "\"UK Government's Medical Supply Price Transparency: Ensuring Fairness and Reasonableness\"",
                "text": "\n* Simplified point 1: The UK government can request information from healthcare providers regarding the cost of medical supplies and services.\n* Simplified point 2: This information can only be used for the purpose of ensuring that the prices of medical supplies and services are fair and reasonable, and that the providers are not overcharging or undercharging for their services.\n* Simplified point 3: The government can also share this information with other organizations, such as local health boards and NHS trusts, to ensure that they are aware of the costs of medical supplies and services.\n* Simplified point 4: The government must consult with relevant bodies representing healthcare providers before making regulations under this act.\n* Simplified point 5: The act does not allow for the use of confidential or commercially sensitive information for purposes other than those specified in the law."
            },
            {
                "length": 159,
                "short": "\"NHS Medical Supplies Regulation Overhaul\"",
                "text": "\n* Simplified point 1: The act repeals certain sections of previous laws related to the cost of medical supplies in the NHS.\n* Simplified point 2: It removes the need for price controls on medical supplies other than health service medicines.\n* Simplified point 3: The act also makes changes to the process for appealing against enforcement decisions related to these medical supplies.\n* Simplified point 4: Additionally, it modifies the territorial limit of the exercise of functions and the extent of the act's provisions.\n* Simplified point 5: Finally, the act sets out the commencement and short title of the legislation."
            }
        ],
        [
            {
                "length": 193,
                "short": "\"UK Healthcare Cost Regulation: Ensuring Affordable Medications & Research Development Investment Recovery\"",
                "text": "\n* Simplified point 1: The Health Service Medical Supplies (Costs) Act 2017 regulates the cost of health service medicines and medical supplies in the UK.\n* Simplified point 2: The act introduces new provisions for remuneration for special medicinal products and enforcement measures for non-compliance.\n* Simplified point 3: The changes aim to ensure that medicinal products are available for the health service on reasonable terms while considering the costs of research and development.\n* Simplified point 4: The act also includes provisions for the recovery of costs incurred in enforcing the orders.\n* Simplified point 5: The act repeals and replaces previous provisions related to the control of prices of medical supplies, and it introduces new provisions for the recovery of costs incurred in enforcing the orders."
            }
        ]
    ],
    "simp_series": null,
    "summary": "The Health Service Medical Supplies (Costs) Act 2017 regulates the cost of healthcare products and services in the United Kingdom. The government may set limits on the prices of medical supplies, and producers must provide information about their products' costs and profits. The goal is to ensure that patients receive necessary treatments at reasonable prices. Producers who do not comply with the regulations risk penalties. The act also establishes procedures for appealing against enforcement decisions related to medical supplies."
}